Stay updated with breaking news from Biomarker Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ALS Phase 2b PARADIGM Trial Completed Patient EnrollmentTopline results expected in Q-4 2023Cash runway beyond topline clinical study readouts, into Q-2 2024CAMBRIDGE, Mass., Aug. 16, 2023... -Today at 09:01 am- MarketScreener
Highlights: ATH434-201 Phase 2 study on track to complete enrollment in Q3 2023 with top-line data expected by the end of 2024 in individuals with...
Praxis Spinal Cord Institute announces its latest grant recipients...
- ATH434 now being evaluated in early and more advanced Multiple System Atrophy - - New trial expected to generate data before ongoing Phase 2 trial - MELBOURNE, Australia and SAN FRANCISCO, May... | May 30, 2023
USA News Group – It’s estimated that 6.7 million Americans over 65 (or more than 1 in 9 seniors) are now living with Alzheimer’s Disease (AD), and the number of diagnoses is on the rise. It’s expected that the burden of those ...